| P2093 | author name string | Gosse J Adema | |
| | Ulrich Bogdahn | |
| | Oliver Grauer | |
| | Annette Lohmeier | |
| | Peter Pöschl | |
| P2860 | cites work | Functional interaction between TGF-beta and IL-12 in human primary allogeneic cytotoxicity and proliferative response | Q71929853 |
| | Generation of large numbers of human dendritic cells from whole blood passaged through leukocyte removal filters: an alternative to standard buffy coats | Q73832572 |
| | T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells | Q74082060 |
| | The effect of TGF-beta1 on immune responses of naïve versus memory CD4+ Th1/Th2 T cells | Q74165096 |
| | p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils | Q74392981 |
| | Characterization of microglial responses to Staphylococcus aureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression | Q74775345 |
| | Cutting edge: IL-12 induces CD4+CD25- T cell activation in the presence of T regulatory cells | Q80345062 |
| | alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity | Q80516665 |
| | Differential activation of astrocytes by innate and adaptive immune stimuli | Q80990228 |
| | A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits | Q24323368 |
| | Selective expression of an interleukin-12 receptor component by human T helper 1 cells | Q24670175 |
| | Mechanisms of TGF-beta signaling from cell membrane to the nucleus | Q27860785 |
| | Dendritic cells and the control of immunity | Q27860918 |
| | Prostanoids and prostanoid receptors in signal transduction | Q28168406 |
| | The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling | Q28243202 |
| | Toll-like receptor control of the adaptive immune responses | Q29547305 |
| | A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers | Q32133166 |
| | Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application | Q33536357 |
| | Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape | Q34136498 |
| | The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier | Q34721182 |
| | The use of dendritic cells in cancer immunotherapy | Q35084257 |
| | Three or more routes for leukocyte migration into the central nervous system | Q35183162 |
| | TIR domain-containing adaptors define the specificity of TLR signaling | Q35617615 |
| | Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells | Q36376864 |
| | Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells | Q37139993 |
| | Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs. | Q40455900 |
| | p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. | Q40524611 |
| | Toll-like receptor 2 (TLR2) mediates activation of stress-activated MAP kinase p38. | Q40747923 |
| | Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta | Q40751238 |
| | Interleukin-12-based immunotherapy against rat 9L glioma | Q40860484 |
| | A constitutive active MEK --> ERK pathway negatively regulates NF-kappa B-dependent gene expression by modulating TATA-binding protein phosphorylation | Q40870326 |
| | Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 |
| | Activation of human dendritic cells through CD40 cross-linking. | Q41440958 |
| | Preferential expression and function of Toll-like receptor 3 in human astrocytes | Q42472896 |
| | Mechanisms of leukocyte trafficking into the CNS. | Q44041690 |
| | Broad expression of Toll-like receptors in the human central nervous system | Q44492400 |
| | TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action. | Q44601976 |
| | TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice | Q44714971 |
| | Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12 | Q45710750 |
| | Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain. | Q48222103 |
| | A dendritic cell vaccine induces protective immunity to intracranial growth of glioma. | Q48603942 |
| | Initiation of immune responses in brain is promoted by local dendritic cells. | Q50796487 |
| | Phenotypical and functional characterization of clinical grade dendritic cells. | Q52010684 |
| | Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. | Q52956682 |
| | Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. | Q54102042 |
| | Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12. | Q55471753 |
| | Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. | Q55475527 |
| | TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. | Q55478696 |
| | TGF regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo | Q58131190 |
| | Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability | Q71615065 |
| P433 | issue | 2 | |
| P921 | main subject | toll-like receptor | Q408004 |
| | dendritic cell | Q506253 |
| P304 | page(s) | 151-161 | |
| P577 | publication date | 2006-11-15 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2. | |
| P478 | volume | 82 | |